DLC1 and infection: Based on evidence, recombinant RABV without DLC1-binding motif (deleted from P) does not inhibit viral entry to the CNS of a mouse model but significantly suppresses the viral transcription (indicated by quantification of RNA transcripts by real-time PCR at the onset of infection) and replication in the CNS, consequently inhibiting the onset of RABV-induced CNS disease.